Johnson & Johnson’s consumer health business is valued at $40 billion ahead of its initial public offering later this year, according to a report by The Wall Street Journal. The soon-to-be spinoff Kenvue aims to raise $3.5 billion or more in the offering, people familiar with the matter told the Journal. The newspaper noted that “the share sale would be by far the biggest of what so far has been a quiet year for IPOs.”
Read the full article: Johnson & Johnson Consumer Health Unit Valued at $40B Ahead of IPO, Report Says //
Source: https://www.cnbc.com/2023/04/24/jj-consumer-health-unit-valued-at-40-billion-for-ipo.html